'We desperately need a ‘no treatment’ trial for DCIS', says Clive Wells, Chairman of the European Working Group on Breast Cancer Pathology, and London Regional Co-ordinator for the United Kingdom’s National Health Service (NHS) National Breast Cancer Screening Programme. Interview: Frank Swain
A first of its kind expert consensus report on Clostridium difficile infection (CDI), contributed to by more than 1,000 healthcare professionals across Europe, has been presented today at the Healthcare Infection Society (HIS) International Congress in Lyon, France. The consensus report aimed to identify a set of expert views on CDI management, in order to determine attitudes to diagnosis,…
With strong links with the West Coast of Africa, France is among countries most likely to experience Ebola, with an estimated 20% chance of cases in the homeland before October ends - a few suspected cases have arisen.
World-renowned experts discussed the situation of predomonant epidemics at the International Roche Infectious Disease Symposium in Barcelona.
Viktor Mayer-Schönberger is a visionary author of the book Big Data, which, as its subtitle suggests, defines the debate over the ‘Revolution That Will Transform How We Live, Work, and Think.’
Founded in Germany 25 years ago, EKF Diagnostics’ PLC HQ is currently in Cardiff, Wales, where the firm is pursuing the development of a molecular assay for specific cancer types.
The University Medical Center in Utrecht (UMCU), The Netherlands, is in the process of creating a multidisciplinary centre of excellence, able to manage resources efficiently while delivering the highest level of patient care and clinical research.
This year’s Journées Internationales de Biologie (JIB) in Paris (8-11 October) will include the new France-Germany Forum on its opening day.
Treat a proficiency testing (PT) sample just like a patient sample. But don't. That has been the message labs have struggled with and in some cases lost their CLIA certificates over.
Health analysts have predicted that DNA sequencing will shift from a laboratory-based setup to point of care testing within the next five years.
Johns Hopkins researchers say they have discovered a chemical alteration in a single human gene linked to stress reactions that, if confirmed in larger studies, could give doctors a simple blood test to reliably predict a person’s risk of attempting suicide.
New molecular technologies to screen drug-resistant TB are replacing, for example, culture-based tests that are slow, require experienced personnel, and need stringent microbiological safety precautions.
Most clinical laboratories use immunoassays routinely to measure 25-hydroxyvitamin D (25OH D) in serum. The metabolites of vitamin D are important in the regulation of calcium and bone metabolism.
No provider has yet been able to cover all IT topics and processes in laboratory software. The solutions currently marketed either support key lab tasks, from requests down to results, or they cover topics such as quality assurance and billing, according to Dr Markus Neumann MD of Dr Neumann & Kindler.
As many laboratories face demands to turn around faster, more accurate patient test results against a backdrop of increasingly stringent quality control and tighter budgets, the search is on for tools to help meet ever-stretching targets.
On the leading edge of automation for medical laboratory testing, Siemens Healthcare rolled out an impressive suite of new products at IFCC WorldLab 2014 in Istanbul, Turkey that are ‘exactly aligned, and even anticipate, customer needs in central lab operations,’ according to Franz Walt, CEO for the Chemistry, Immunoassay, Automation and Diagnostics IT business unit within Siemens’…
Researchers at Johns Hopkins Bayview Medical Center used two relatively simple tactics to significantly reduce the number of unnecessary blood tests to assess symptoms of heart attack and chest pain and to achieve a large decrease in patient charges.
Laboratories are an essential part of effective modern healthcare. They provide clinicians with vital information that helps them make life-saving decisions, diagnose conditions and monitor patient treatment.
For several decades pathologists worldwide have been under increasing pressure to handle a steady increase in laboratory tests with a steady decrease in finance and staff.
The GenSPEED Test System developed by Greiner Bio-One combines crude lysis of bacteria with multiplex-PCR before the final automated analysis of PCR-products in the new GenSPEED R2 device.
Some years ago telepathology – a complex but well developed procedure where histology specimens are photographed using a camera mounted on a microscope and transmitted – was thought to be the wave of the future.
For several decades, pathologists worldwide have been under increasing pressure to handle a steady increase in laboratory tests with a steady decrease in the amount of financial and staff resources. Add to this the escalating volume of increasingly complex, sophisticated testing and the importance of pathology informatics is evident.
Having convinced medical labs across Denmark that its suite of image analysis software can provide a solution to the crushing burden of in vitro diagnostics (IVD), VisioPharm is offering it to pathologists worldwide
Scientists in the UK are working to develop a hand-held testing device to provide same day diagnosis from a patient’s bedside. The device will use disposable cartridges and utilise printed circuit board technology (PCB) that will allow a fast and low-cost diagnosis.
This April, in San Jose, California, the portable lab took central stage at the American Association for Clinical Chemistry’s (AACC) annual forum for emerging clinical diagnostic technologies – a most appropriate topic for the Silicon Valley venue where so many world-changing computer and communications innovations have been born.
